Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin J Ostrin

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Cancers|June 19, 2024
Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health StudyLulu Song, Ehsan Irajizad, Andrew Rundle, et al.
International Journal of Cancer|November 15, 2017
Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositolNese Unver, Oliver Delgado, Kirubel Zeleke, et al.
Cancers|February 11, 2023
Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor PrognosisRicardo A León-Letelier, Ali H Abdel Sater, Yihui Chen, et al.
Journal of Thoracic Disease|September 15, 2025
Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?Kevin C McGann, Timothy A Khalil, Michael N Kammer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2025
Impact of Comorbidities on the Mortality Benefits of Lung Cancer Screening: A Post-Hoc Analysis of the PLCO and NLST TrialsSebastien Gendarme, Ehsan Irajizad, James P Long, et al.
Cancers|September 9, 2022
Contributions of Circulating microRNAs for Early Detection of Lung CancerJody Vykoukal, Johannes F Fahrmann, Nikul Patel, et al.
Development (Cambridge, England)|February 15, 2018
β-Catenin maintains lung epithelial progenitors after lung specificationEdwin J Ostrin, Danielle R Little, Kamryn N Gerner-Mauro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 2, 2020
Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary NodulesEdwin J Ostrin, Leonidas E Bantis, David O Wilson, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2025
Natural history models for lung Cancer: A scoping reviewRenu Sara Nargund, Sayaka Ishizawa, Maryam Eghbalizarch, et al.
Cancer Research|June 25, 2017
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling PathwaySatyendra C Tripathi, Johannes F Fahrmann, Muge Celiktas, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancers|June 19, 2024
Validation of a Blood-Based Protein Biomarker Panel for a Risk Assessment of Lethal Lung Cancer in the Physicians' Health StudyLulu Song, Ehsan Irajizad, Andrew Rundle, et al.
International Journal of Cancer|November 15, 2017
Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositolNese Unver, Oliver Delgado, Kirubel Zeleke, et al.
Cancers|February 11, 2023
Kynureninase Upregulation Is a Prominent Feature of NFR2-Activated Cancers and Is Associated with Tumor Immunosuppression and Poor PrognosisRicardo A León-Letelier, Ali H Abdel Sater, Yihui Chen, et al.
Journal of Thoracic Disease|September 15, 2025
Biomarkers for the diagnosis of indeterminate pulmonary nodules: are we there yet?Kevin C McGann, Timothy A Khalil, Michael N Kammer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 11, 2025
Impact of Comorbidities on the Mortality Benefits of Lung Cancer Screening: A Post-Hoc Analysis of the PLCO and NLST TrialsSebastien Gendarme, Ehsan Irajizad, James P Long, et al.
Cancers|September 9, 2022
Contributions of Circulating microRNAs for Early Detection of Lung CancerJody Vykoukal, Johannes F Fahrmann, Nikul Patel, et al.
Development (Cambridge, England)|February 15, 2018
β-Catenin maintains lung epithelial progenitors after lung specificationEdwin J Ostrin, Danielle R Little, Kamryn N Gerner-Mauro, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 2, 2020
Contribution of a Blood-Based Protein Biomarker Panel to the Classification of Indeterminate Pulmonary NodulesEdwin J Ostrin, Leonidas E Bantis, David O Wilson, et al.
Lung Cancer (Amsterdam, Netherlands)|April 2, 2025
Natural history models for lung Cancer: A scoping reviewRenu Sara Nargund, Sayaka Ishizawa, Maryam Eghbalizarch, et al.
Cancer Research|June 25, 2017
MCAM Mediates Chemoresistance in Small-Cell Lung Cancer via the PI3K/AKT/SOX2 Signaling PathwaySatyendra C Tripathi, Johannes F Fahrmann, Muge Celiktas, et al.
Pageof 6